ORGANIZATION

Drug Wholesalers Post Virtually Flat Sales in FY2017: JPWA

August 10, 2018
Member firms of the Federation of Japan Pharmaceutical Wholesalers Association (JPWA) saw their sales level off in FY2017, at a paltry 0.08% rise year on year, due to dwindled sales of hepatitis C drugs and continuing generic inroads, according to…

To read the full story

ORGANIZATION

By Reiji Anasako

Kyowa Hakko Kirin’s first and only Rituxan (rituximab) biosimilar in Japan is showing a faster-than-expected uptake in the market, with the company racking up 4.3 billion yen from the cancer drug in 2018, far beyond its initial 3.2 billion yen…

Members of a key reimbursement policy panel appear to be becoming more and more open to the industry’s call for…

By Philip Carrigan

With a cursory glance, recruitment is easily defined. We’re here to help place candidates into the vacancies our clients need to fill. Armed with a pen and paper, you could even map out the process.• We study the market• We…

By Shinya Sato

As 2019 rolls in, we expect to see a flurry of approvals in the Japanese regenerative medicine arena, with regulatory decisions anticipated by the end of the year for Novartis Pharma’s CAR-T therapy and many more products, which could bring…